SCHEMBL5369948

SCHEMBL5369948

Cc1ccc(S(=O)(=O)Nc2ccc(SCc3ccc(SC(F)(F)F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.53
CASP6 P55212 1/20 0.47
PABPC1 P11940 1/20 0.46
GFER P55789 1/20 0.44
MCL1 Q07820 1/20 0.44
BCL2A1 Q16548 1/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 2/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 1/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382518 0.90 POLB (0.47) POLBCASP6PABPC1GFERALDH1A1
SCHEMBL5371856 0.90 POLB (0.53) POLBCASP6PABPC1GFERMCL1
SCHEMBL5386741 0.89 POLB (0.56) POLBCASP6PABPC1GFERMCL1
Cp-778875 SCHEMBL1600965 0.89 POLB (0.58) POLBCASP6PABPC1GFERMCL1
SCHEMBL5388043 0.88 POLB (0.59) POLBCASP6PABPC1ALDH1A1SMN1; SMN2
SCHEMBL5376747 0.87 POLB (0.54) POLBCASP6PABPC1GFERMCL1
SCHEMBL5388054 0.87 POLB (0.56) POLBCASP6PABPC1GFERMCL1
SCHEMBL14437715 0.87 POLB (0.56) POLBCASP6PABPC1GFERMCL1
SCHEMBL5375209 0.87 POLB (0.58) POLBCASP6PABPC1GFERMCL1
SCHEMBL5373144 0.86 POLB (0.53) POLBCASP6PABPC1GFERMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885CASP6 3606/4885PABPC1 3612/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885CASP6 3811/4885PABPC1 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.